116,90 €
129,89 €
-10% with code: EXTRA
Ligand Binding in the Transmembrane Region of Metabotropic Glutamate Receptors
Ligand Binding in the Transmembrane Region of Metabotropic Glutamate Receptors
116,90
129,89 €
  • We will send in 10–14 business days.
Group I metabotropic glutamate receptors (mGluRs) play an important role in the treatment of numerous neurodegenerative, cognitive and psychiatric dis-orders. How can we identify exogenous ligands mediating the effects of mGluRs? How do these ligands affect the receptor? The author Tobias Noeske presents the establishment of strategies for the identification and optimization of molecules acting as non-competitive anta-gonists of group I mGluRs. These strategies ensure high diversity in the iden…
  • SAVE -10% with code: EXTRA

Ligand Binding in the Transmembrane Region of Metabotropic Glutamate Receptors (e-book) (used book) | bookbook.eu

Reviews

Description

Group I metabotropic glutamate receptors (mGluRs) play an important role in the treatment of numerous neurodegenerative, cognitive and psychiatric dis-orders. How can we identify exogenous ligands mediating the effects of mGluRs? How do these ligands affect the receptor? The author Tobias Noeske presents the establishment of strategies for the identification and optimization of molecules acting as non-competitive anta-gonists of group I mGluRs. These strategies ensure high diversity in the identi-fied chemotypes not resembling original reference molecules ("scaffold-hop-ping"). The detection of new scaffolds, in turn, is divided into two ap-proa-ches: First the development of pharmacological assays to screen com-pounds at a certain target for their bioactivity, and second the evaluation of com-pu-ter aided methods for the identification of virtual hits to be screened on the pharmacological assays. Promising molecules were optimized regarding bio-activity and selectivity, their binding mode investigated and, fi-nally, com-pared to existing lead compounds. This book addresses scientists in academia and industry working in early stage drug discovery, predominantly in computer aided drug design.

EXTRA 10 % discount with code: EXTRA

116,90
129,89 €
We will send in 10–14 business days.

The promotion ends in 20d.20:20:24

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 1,30 Book Euros!?

Group I metabotropic glutamate receptors (mGluRs) play an important role in the treatment of numerous neurodegenerative, cognitive and psychiatric dis-orders. How can we identify exogenous ligands mediating the effects of mGluRs? How do these ligands affect the receptor? The author Tobias Noeske presents the establishment of strategies for the identification and optimization of molecules acting as non-competitive anta-gonists of group I mGluRs. These strategies ensure high diversity in the identi-fied chemotypes not resembling original reference molecules ("scaffold-hop-ping"). The detection of new scaffolds, in turn, is divided into two ap-proa-ches: First the development of pharmacological assays to screen com-pounds at a certain target for their bioactivity, and second the evaluation of com-pu-ter aided methods for the identification of virtual hits to be screened on the pharmacological assays. Promising molecules were optimized regarding bio-activity and selectivity, their binding mode investigated and, fi-nally, com-pared to existing lead compounds. This book addresses scientists in academia and industry working in early stage drug discovery, predominantly in computer aided drug design.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)